Blood Vessels in the Human Body: Anatomy, Physiology, Pathophysiology, and the Frontiers of Vascular Medicine
1. Zarina Zhamaldinovna Toichieva
2. Ramesh Rubini
3. Karthikeyan Kavya
4. Karthikeyan Manisha
5. Kumaresan Dharaniya Shree
(1. Lecturer, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic
2. Student, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic
3. Student, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic
4. Student, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic
5. Student, International Medical Faculty, Osh State University, Osh, Kyrgyz Republic.)
Abstract
The blood vessels of the human body constitute an extraordinary network of biological engineering, comprising approximately 60,000 miles of arteries, veins, and capillaries that sustain every cell with oxygen, nutrients, and hormonal signals while removing metabolic waste. This review provides a comprehensive examination of the anatomy, physiology, and pathophysiology of the human vascular system, integrating classical anatomical knowledge with the most recent advances in vascular biology, clinical medicine, and surgical innovation. Drawing upon authoritative anatomical sources, recent peer-reviewed research on angiogenesis, endothelial function, and vascular disease, and contemporary clinical guidelines for hypertension and atherosclerosis management, the article explores the structural organization of arteries, veins, and capillaries, the dynamic regulatory functions of the vascular endothelium, the mechanisms of vascular formation and remodeling, and the pathological processes that compromise vascular integrity. The analysis further examines the lymphatic system as an integral component of vascular physiology, the evolving landscape of endovascular and open surgical interventions, and the emerging frontiers of stem cell-based vascular regeneration and bioprinting. The findings reveal that while our understanding of vascular biology has advanced remarkably, the global burden of vascular diseases, including atherosclerosis, hypertension, and peripheral artery disease, continues to escalate, driven by aging populations, lifestyle factors, and persistent inequities in healthcare access. The review concludes that the future of vascular medicine lies not merely in technological innovation but in the integration of molecular biology, precision medicine, and public health strategies that address the root causes of vascular disease.
Keywords: blood vessels, vascular system, endothelium, angiogenesis, atherosclerosis, hypertension, endovascular surgery, lymphatic system, vascular regeneration
1. Introduction
The human body is, in essence, a vessel for blood. Every thought, every movement, every breath, every heartbeat depends upon the ceaseless circulation of fluid through a network of tubes so extensive that, if laid end to end, they would encircle the Earth more than twice. This is not poetic exaggeration but anatomical fact: the combined length of all blood vessels in an adult human is approximately 60,000 miles, or more than 96,500 kilometers, a figure that encompasses the major arteries and veins visible to the naked eye and the billions of capillaries so fine that a single red blood cell must pass through them in single file. The vascular system is not merely a passive conduit for blood but a dynamic, living organ system that actively regulates blood pressure, distributes nutrients, responds to hormonal signals, participates in immune defense, and adapts continuously to the changing demands of tissues and organs.
The study of blood vessels has occupied a central place in medical science since antiquity. The Greek physician Hippocrates recognized the importance of the pulse in diagnosis, and Galen's theories of blood movement, though erroneous in their details, established the conceptual framework for centuries of inquiry. William Harvey's demonstration of the circulation of blood in 1628, one of the foundational achievements of modern medicine, transformed understanding of the cardiovascular system and established the vascular network as the central highway of physiological function. Yet despite nearly four centuries of progress, the blood vessels continue to yield secrets that challenge our understanding and demand new therapeutic approaches.
The contemporary relevance of vascular biology extends far beyond the confines of academic anatomy. Diseases of the blood vessels, collectively termed cardiovascular diseases, are the leading cause of death globally, responsible for approximately 17.9 million deaths annually, or 32 percent of all deaths worldwide. Atherosclerosis, the progressive accumulation of lipid-rich plaques in arterial walls, underlies the majority of heart attacks and strokes. Hypertension, the sustained elevation of blood pressure that damages vessel walls and accelerates atherosclerosis, affects an estimated 1.28 billion adults globally, with two-thirds residing in low- and middle-income countries. Peripheral artery disease, the narrowing of vessels supplying the limbs, affects more than 200 million people worldwide and is a major cause of amputation and disability. Venous diseases, including deep vein thrombosis and chronic venous insufficiency, contribute substantially to morbidity and healthcare costs. The lymphatic system, long overshadowed by its blood vascular counterpart, is now recognized as essential for immune function, fluid homeostasis, and cancer metastasis.
The past decade has witnessed extraordinary advances in vascular medicine. The 2025 update to the American Heart Association and American College of Cardiology guidelines for hypertension management has introduced new risk-based treatment thresholds, refined blood pressure targets, and emphasized the integration of lifestyle modification with pharmacological therapy. Endovascular surgery has transformed the treatment of aneurysms, occlusive disease, and venous disorders, with minimally invasive techniques now accounting for the majority of vascular procedures in many centers. Research into angiogenesis, the formation of new blood vessels, has revealed previously unknown mechanisms of vessel development, including coalescent angiogenesis, and has opened new avenues for therapeutic angiogenesis in ischemic tissues. Stem cell-based approaches to vascular regeneration, once speculative, are now entering clinical trials with promising results.
This review aims to provide a comprehensive, evidence-based examination of the blood vessels in the human body, spanning from the molecular biology of the endothelial cell to the macroscopic anatomy of the great vessels, from the physiological regulation of vascular tone to the pathological processes of atherosclerosis and hypertension, and from the established practices of vascular surgery to the emerging frontiers of regenerative medicine. The ultimate objective is to illuminate the extraordinary complexity of the vascular system and the profound implications of vascular health for human wellbeing.
2. Materials and Methods
This review was conducted as a narrative synthesis of authoritative anatomical texts, peer-reviewed literature, clinical guidelines, and recent research reports pertaining to the anatomy, physiology, and pathology of blood vessels. The search strategy encompassed electronic databases including PubMed, Scopus, and Google Scholar, with search terms including combinations of "blood vessels," "vascular system," "arteries," "veins," "capillaries," "endothelium," "angiogenesis," "vasculogenesis," "atherosclerosis," "hypertension," "peripheral artery disease," "endovascular surgery," "lymphatic vessels," "vascular regeneration," and "stem cells." The search was restricted to publications in English from 2020 to 2026, with selective inclusion of earlier foundational works where necessary for historical context.
Inclusion criteria encompassed original research articles, systematic reviews, meta-analyses, clinical practice guidelines from professional societies (American Heart Association, American College of Cardiology, European Society of Cardiology), and authoritative anatomical references (StatPearls, Cleveland Clinic, Texas Heart Institute). Studies and reports were included regardless of geographical focus, provided that they offered sufficient methodological detail to permit critical appraisal. Exclusion criteria included non-peer-reviewed sources, commercial promotional materials, and studies lacking sufficient detail for evaluation.
Data extraction focused on anatomical descriptions, physiological mechanisms, pathological processes, clinical outcomes, and emerging therapeutic approaches. Particular attention was paid to the 2025 AHA/ACC guideline for hypertension management, recent research on angiogenesis mechanisms published in 2024, and contemporary data on endovascular surgery trends. Where clinical or epidemiological data are presented, sample sizes, confidence intervals, and statistical significance are reported where available.
The quality of included sources was assessed using established critical appraisal criteria, with preference given to peer-reviewed research in high-impact journals, authoritative clinical guidelines, and recognized anatomical references. However, no formal meta-analysis was performed due to the anticipated heterogeneity in data sources and outcome measures. This review adopts a narrative synthesis approach that prioritizes contextual interpretation and the integration of anatomical, physiological, and clinical perspectives.
3. Results
3.1 Gross Anatomy and Structural Organization of Blood Vessels
The vascular system is organized hierarchically, with vessels of progressively smaller caliber branching from the central pump of the heart to reach every tissue and then converging back to return blood to the heart. The major vessels include approximately 20 arteries that traverse the body's tissues, branching into smaller arterioles, which further subdivide into capillaries, the true sites of exchange between blood and tissues. From capillaries, blood passes into venules, which join to form veins, ultimately returning to the heart through the great venous channels. The body contains approximately 160 arteries and 200 veins of significant size, but the vast majority of the vascular network consists of the billions of capillaries, venules, and arterioles that constitute the microcirculation.
The most important blood vessel in the body is the aorta, the main artery that carries oxygenated blood away from the left ventricle of the heart. The aorta descends through the chest, passes through the diaphragm, and continues into the abdomen, where it bifurcates into the two common iliac arteries that supply the lower limbs and pelvis. Along its course, the aorta gives rise to branches that supply the head and neck (brachiocephalic trunk, left common carotid artery, left subclavian artery), the upper limbs (subclavian arteries continuing as axillary and brachial arteries), the thoracic organs (intercostal arteries, bronchial arteries), and the abdominal viscera (celiac trunk, superior mesenteric artery, renal arteries, inferior mesenteric artery). The aorta's wall is exceptionally thick and elastic, enabling it to withstand the high pressures generated by ventricular systole and to maintain continuous blood flow during diastole through the Windkessel effect.
The principal venous return channels are the superior and inferior vena cava. The superior vena cava, located in the upper right portion of the mediastinum, collects deoxygenated blood from the head, neck, upper limbs, and thoracic wall, draining into the right atrium. The inferior vena cava, positioned to the right of the abdominal aorta, returns blood from the lower limbs, pelvis, and abdominal organs. The venous system is characterized by low pressure and high capacitance, with thin, distensible walls that can accommodate large volumes of blood. At any given moment, approximately three-quarters of the circulating blood volume resides within the venous system, which functions as a reservoir that can be mobilized during exercise or hemorrhage.
The structural integrity of all blood vessels is maintained by three concentric layers of tissue. The innermost layer, the tunica intima, consists of a single layer of endothelial cells resting on a basement membrane. This endothelial lining is not merely a passive barrier but an active regulatory interface that controls vascular tone, prevents thrombosis, modulates inflammation, and regulates the permeability of the vessel wall to nutrients, hormones, and immune cells. The middle layer, the tunica media, is composed predominantly of smooth muscle cells arranged in circular layers, interspersed with elastic fibers and collagen. The thickness and composition of the media vary according to the vessel's function: arteries subjected to high pulsatile pressure have thick, elastic media, while veins, which operate under low pressure, have thinner media with less elastic tissue. The outermost layer, the tunica adventitia, contains connective tissue, nerves, and the vasa vasorum, small vessels that supply blood to the walls of larger arteries and veins. The vasa vasorum, literally "vessels of vessels," are essential for nourishing the thick walls of the aorta and other large vessels, which cannot receive adequate oxygen and nutrients by diffusion from the luminal blood alone.
3.2 The Endothelium: A Dynamic Regulatory Interface
The endothelium, once regarded as a simple passive lining of blood vessels, is now recognized as one of the most metabolically active and functionally versatile tissues in the body. Comprising approximately 60 trillion endothelial cells weighing a total of 1 kilogram, the endothelium forms an interface between blood and tissues that regulates virtually every aspect of vascular function. The endothelial cell is a master regulator of vascular tone, producing both vasodilators, including nitric oxide, prostacyclin, and endothelium-derived hyperpolarizing factor, and vasoconstrictors, such as endothelin-1 and angiotensin II. The balance between these opposing signals determines the caliber of resistance vessels and thus systemic blood pressure.
Nitric oxide, synthesized by endothelial nitric oxide synthase from L-arginine, is the principal mediator of endothelium-dependent vasodilation. It diffuses to the underlying smooth muscle cells, where it activates soluble guanylate cyclase, increasing cyclic GMP and causing relaxation. Beyond its vasodilatory function, nitric oxide inhibits platelet aggregation, leukocyte adhesion, and smooth muscle proliferation, serving as a critical anti-atherosclerotic factor. The impairment of nitric oxide bioavailability, whether through reduced synthesis, increased degradation by reactive oxygen species, or decreased responsiveness of smooth muscle cells, is a hallmark of endothelial dysfunction and an early event in the pathogenesis of atherosclerosis and hypertension.
The endothelium also plays a central role in regulating vascular permeability. In capillaries, the endothelial barrier is maintained by tight junctions, adherens junctions, and gap junctions that control the paracellular passage of molecules. In response to inflammatory mediators such as histamine, bradykinin, and vascular endothelial growth factor, endothelial cells can undergo contraction, creating intercellular gaps that increase permeability and allow the extravasation of plasma proteins and leukocytes. This regulated permeability is essential for immune surveillance and wound healing but becomes pathological when excessive, as in septic shock, acute respiratory distress syndrome, and diabetic retinopathy.
The endothelial surface is covered by the glycocalyx, a gel-like layer of membrane-bound proteoglycans and glycoproteins that extends into the vascular lumen. The glycocalyx functions as a mechanosensor, transmitting shear stress from flowing blood to the endothelial cytoskeleton, and as a barrier that prevents platelet adhesion and leukocyte attachment. Damage to the glycocalyx, which can occur in response to hyperglycemia, hyperlipidemia, inflammation, and oxidative stress, is an early event in vascular disease and contributes to increased permeability and prothrombotic tendency.
Endothelial dysfunction, defined as an imbalance between vasodilation and vasoconstriction, anti-inflammatory and pro-inflammatory signaling, and antithrombotic and prothrombotic properties, is the common pathway through which cardiovascular risk factors exert their deleterious effects. Hypertension, diabetes, hyperlipidemia, smoking, obesity, and physical inactivity all impair endothelial function, creating a pro-atherogenic environment that initiates and accelerates the formation of atherosclerotic plaques. The assessment of endothelial function, typically by measuring flow-mediated dilation of the brachial artery, has emerged as a valuable prognostic tool and a surrogate endpoint in clinical trials of cardiovascular interventions.
3.3 Angiogenesis and Vascular Remodeling
The formation of new blood vessels is essential for embryonic development, wound healing, tissue repair, and the adaptive response to ischemia. Two principal processes govern vascular formation: vasculogenesis, the de novo assembly of blood vessels from endothelial precursor cells during embryonic development, and angiogenesis, the sprouting or splitting of new vessels from pre-existing ones. While vasculogenesis is largely restricted to embryonic and early postnatal life, angiogenesis continues throughout adulthood and is critical for physiological processes such as endometrial cycling, exercise-induced muscle adaptation, and collateral vessel development in response to arterial occlusion.
Recent research has significantly expanded our understanding of the mechanisms of angiogenesis, revealing a diversity of modes beyond the classical sprouting paradigm. Sprouting angiogenesis, the best-characterized mechanism, involves the differentiation of endothelial cells into tip cells that lead migration and stalk cells that proliferate and form the lumen, driven by vascular endothelial growth factor and other angiogenic cytokines. Intussusceptive angiogenesis, in contrast, splits existing vessels by the formation of transvascular tissue pillars, increasing vascular surface area without endothelial cell proliferation. This process is rapid, occurring within minutes to hours, and is particularly important in tumor vascularization and tissue remodeling.
In 2022, a new mode of angiogenesis was formally recognized: coalescent angiogenesis, the fusion of capillaries to increase blood flow where needed. This mechanism, previously observed in avian embryonic development, has now been established as a bona fide mode of vessel formation, though its role in postnatal and pathological angiogenesis remains to be fully elucidated. Other modes include vessel elongation, vessel co-option by tumors, and vasculogenic mimicry, in which cancer cells themselves form vessel-like structures. The recognition of this diversity has important implications for therapeutic strategies, as anti-angiogenic drugs that target sprouting may inadvertently promote alternative modes of vascularization.
The molecular regulation of angiogenesis is orchestrated by a complex interplay of growth factors, receptors, and signaling pathways. Vascular endothelial growth factor, particularly VEGF-A, is the master regulator of sprouting angiogenesis, signaling through VEGF receptor-2 to promote endothelial proliferation, migration, and survival. Fibroblast growth factors, platelet-derived growth factor, angiopoietins, and transforming growth factor-beta modulate vessel maturation, pericyte recruitment, and basement membrane deposition. The Notch signaling pathway regulates the tip-stalk cell differentiation, ensuring that only a subset of endothelial cells acquire the invasive phenotype necessary for sprouting.
A groundbreaking study published in 2024 has revealed the critical importance of mechanical forces in blood vessel formation. Researchers discovered that tensile forces between endothelial cells, regulated by the proteins Heg1 and Ccm1, are essential for proper vessel assembly. Coordinated contractile forces along cell-cell junctions promote the coordinated growth of blood vessels, with tiny forces generated by rhythmic cellular contraction stabilizing junctions and maintaining shape. When the balance of these forces is disrupted, defective vessels develop, potentially contributing to vascular malformations such as cerebral cavernous malformations. These findings open new avenues for understanding vascular disorders and developing targeted therapies.
Postnatal vasculogenesis, the recruitment of circulating endothelial progenitor cells to sites of ischemia or injury, represents another mechanism of vascular repair. These progenitor cells, which can be mobilized from bone marrow by factors such as granulocyte colony-stimulating factor and statins, incorporate into nascent vessels or promote angiogenesis through paracrine secretion of growth factors. The therapeutic potential of endothelial progenitor cells for ischemic diseases, including myocardial infarction and peripheral artery disease, is under active investigation.
3.4 The Lymphatic System: The Forgotten Vascular Network
The lymphatic system, long overshadowed by the blood vascular system in medical education and research, is now recognized as an essential component of vascular physiology with critical roles in fluid homeostasis, immune surveillance, and lipid absorption. The lymphatic vessels form a parallel network that collects interstitial fluid, filters it through lymph nodes, and returns it to the venous circulation, maintaining the balance of fluid between blood and tissues.
Lymphatic capillaries are structurally distinct from blood capillaries. They are larger in diameter, have closed or blind-ended terminations, and possess highly permeable walls that allow fluid to enter but not exit. The endothelial cells of lymphatic capillaries are joined by overlapping junctions that function as one-way valves, opening in response to increased interstitial pressure to admit fluid and closing to prevent backflow. From lymphatic capillaries, lymph passes into progressively larger lymphatic vessels, which contain smooth muscle and intrinsic contractility that propels lymph toward the heart. Valves within these vessels ensure unidirectional flow, while skeletal muscle contractions and respiratory pressure changes provide additional driving forces.
The lymphatic system includes approximately 400 to 450 lymph nodes distributed throughout the body, with the highest concentration in the abdomen, neck, and axillae. These nodes function as filtration and immune surveillance stations, where lymph is exposed to macrophages, dendritic cells, and lymphocytes that detect and respond to pathogens and foreign antigens. The spleen, the largest lymphoid organ, filters blood rather than lymph, removing senescent red blood cells and serving as a reservoir for immune cells. The thymus is responsible for the maturation of T lymphocytes, while red bone marrow produces all blood and immune cell precursors.
The two main lymphatic trunks are the right lymphatic duct and the thoracic duct. The right lymphatic duct drains lymph from the right upper quadrant of the body, including the right side of the head and neck, the right upper limb, and the right side of the thorax, emptying into the right subclavian vein. The thoracic duct, the larger of the two, collects lymph from the remainder of the body, including the lower limbs, abdomen, left thorax, left upper limb, and left side of the head and neck, and also drains into the left subclavian vein. The convergence of lymphatic and venous circulation at the venous angles represents the completion of the extracellular fluid cycle.
The clinical significance of the lymphatic system extends beyond its role in immune function to encompass the pathophysiology of lymphedema, the debilitating accumulation of interstitial fluid that occurs when lymphatic drainage is impaired. Primary lymphedema, resulting from genetic defects in lymphatic development, and secondary lymphedema, most commonly caused by surgical dissection or radiation therapy for cancer, affect millions of people worldwide. The lymphatic system also plays a critical role in cancer metastasis, as tumor cells can invade lymphatic vessels and spread to regional lymph nodes, making the lymphatic vasculature both a target for therapeutic intervention and a prognostic indicator.
3.5 Pathophysiology of Blood Vessels: Atherosclerosis and Hypertension
Atherosclerosis is the defining pathological process of arterial disease, underlying the majority of myocardial infarctions, strokes, and peripheral vascular events. It is characterized by the progressive accumulation of lipids, inflammatory cells, smooth muscle cells, and extracellular matrix within the arterial wall, forming plaques that narrow the vessel lumen, compromise blood flow, and can rupture to precipitate acute thrombotic occlusion.
The pathogenesis of atherosclerosis begins with endothelial dysfunction, induced by cardiovascular risk factors including elevated low-density lipoprotein cholesterol, hypertension, diabetes, smoking, and systemic inflammation. The dysfunctional endothelium becomes permeable to lipoproteins, which accumulate in the subendothelial space and undergo oxidative modification. Oxidized LDL is pro-inflammatory, attracting monocytes that differentiate into macrophages and engulf lipids to become foam cells, the hallmark of the early fatty streak. As the lesion progresses, smooth muscle cells migrate from the media to the intima, proliferate, and secrete collagen and other matrix components, forming a fibrous cap that overlies a lipid-rich necrotic core.
The stability of the atherosclerotic plaque determines its clinical behavior. Stable plaques have thick fibrous caps, small lipid cores, and minimal inflammation, causing chronic ischemic symptoms such as angina or claudication. Vulnerable plaques, in contrast, have thin fibrous caps, large lipid cores, abundant inflammatory cells, and neovascularization from the vasa vasorum, making them prone to rupture or erosion. When a plaque ruptures, the exposed thrombogenic core triggers platelet activation and coagulation cascade, leading to the formation of an occlusive thrombus that causes acute myocardial infarction, unstable angina, or stroke.
The management of atherosclerosis has been transformed by the recognition that LDL cholesterol is the primary driver of plaque formation and that aggressive LDL reduction can stabilize and even regress plaques. Statins, which inhibit HMG-CoA reductase and reduce cholesterol synthesis, are the cornerstone of pharmacotherapy, reducing cardiovascular events and mortality across a wide range of risk categories. The 2025 AHA/ACC guideline for hypertension management emphasizes that statin therapy is the mainstay for lowering LDL cholesterol and reducing cardiovascular events, with treatment goals of LDL below 100 mg/dL for primary prevention and below 70 mg/dL for secondary prevention. For established atherosclerotic cardiovascular disease, revascularization procedures including angioplasty, stenting, and bypass surgery are indicated to restore blood flow to ischemic territories.
Hypertension, defined as sustained elevation of blood pressure above 130/80 mmHg according to the 2025 AHA/ACC guideline, is both a cause and a consequence of vascular pathology. The 2025 guideline represents a significant evolution from the 2017 framework, introducing new terminology, refined treatment thresholds, and an emphasis on cardiovascular risk estimation to guide pharmacological therapy. The guideline recommends that adults with hypertension and clinical cardiovascular disease, or those at increased 10-year cardiovascular risk, should initiate antihypertensive medication when average systolic blood pressure is 130 mmHg or higher or diastolic blood pressure is 80 mmHg or higher. For adults at lower predicted risk, lifestyle interventions should be encouraged first, with medication initiated if blood pressure remains at or above 130/80 mmHg after a 3- to 6-month trial.
The pathophysiology of hypertension involves multiple mechanisms, including increased sympathetic nervous system activity, activation of the renin-angiotensin-aldosterone system, renal sodium retention, vascular stiffness, and endothelial dysfunction. The tunica media of resistance arteries undergoes remodeling in response to sustained high pressure, with smooth muscle cell hypertrophy and hyperplasia, collagen deposition, and reduced lumen diameter that further increases peripheral resistance. Large arteries become stiffened with age and disease, losing their elastic recoil and increasing systolic pressure while decreasing diastolic pressure, a pattern that elevates pulse pressure and cardiovascular risk.
The 2025 guideline recommends four classes of first-line antihypertensive agents: thiazide-type diuretics, long-acting dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibitors, and angiotensin II receptor blockers. Beta-blockers are reserved for patients with compelling indications such as heart failure or coronary artery disease, as they are less effective than other classes in preventing stroke. The guideline emphasizes that good blood pressure control prevents stroke, heart failure, and kidney disease, with a desirable blood pressure target of less than 130/85 mmHg. Lifestyle modifications, including sodium reduction, the DASH eating plan, weight management, physical activity, and moderation of alcohol intake, are foundational to hypertension management and can reduce blood pressure by 3 to 7 mmHg systolic in hypertensive individuals.
3.6 Endovascular and Open Vascular Surgery: Evolving Paradigms
The treatment of vascular disease has undergone a revolutionary transformation with the advent of endovascular techniques, which have progressively displaced open surgical approaches for many indications. Endovascular surgery involves the access of blood vessels through small punctures, typically in the groin, using catheters, guidewires, balloons, and stents under imaging guidance, avoiding the large incisions and tissue dissection of traditional open surgery.
The United States leads globally in vascular and endovascular procedure volume, with over 1.5 million procedures performed annually. Endovascular procedures now dominate the market, accounting for nearly 67 percent of total vascular surgeries, with a 31 percent year-on-year increase between 2022 and 2024. Angioplasty and stenting comprise over 60 percent of the vascular caseload in many hospitals, and 78 percent of endovascular procedures in 2023 were conducted under advanced imaging modalities such as intravascular ultrasound and fluoroscopy.
For aortic aneurysm repair, endovascular aortic repair (EVAR) has become the preferred approach for many patients. In the United Kingdom, 62 percent of elective infra-renal abdominal aortic aneurysm repairs in 2024 were performed as EVAR, compared to 38 percent as open repair. For ruptured abdominal aortic aneurysms, the proportion of EVAR increased to 46 percent in 2024, up from 30 percent in 2018. The in-hospital postoperative mortality for ruptured aneurysm repair was 20.0 percent for EVAR compared to 45.7 percent for open repair, though this comparison is confounded by selection bias, as patients undergoing open repair may represent more complex cases unsuitable for endovascular intervention.
For peripheral artery disease, endovascular techniques including balloon angioplasty, drug-eluting stents, and drug-coated balloons have revolutionized the management of lower limb ischemia. In the United Kingdom, 9,636 endovascular lower limb revascularization procedures were performed in 2024, compared to 6,982 open bypass procedures. Hybrid procedures, combining open and endovascular techniques, accounted for 14.8 percent of lower limb revascularizations, up from 9.9 percent in 2020, reflecting the growing trend toward tailored approaches that leverage the strengths of both modalities. The prevalence of diabetes among patients undergoing revascularization has increased to 50.6 percent, highlighting the need for integrated vascular-diabetic care pathways.
The training of vascular surgeons has adapted to this evolving landscape. Analysis of national case log data from 2007 to 2024 reveals that graduating vascular surgery fellows are performing an increasing number of endovascular procedures, with an average increase of 5.6 cases per year, while open surgical case volumes have remained stable with no significant trend. This shift raises concerns about the maintenance of open surgical competency, particularly for complex cases where endovascular approaches are unsuitable or have failed. Hybrid operating rooms, equipped with both open surgical capabilities and advanced imaging for endovascular procedures, are increasingly adopted to facilitate seamless transitions between techniques.
Innovation in endovascular technology continues to accelerate. Drug-eluting stents have reduced restenosis rates by 30 percent compared to bare metal stents. Bioresorbable stents, which dissolve after providing temporary scaffolding, have seen a 23 percent increase in adoption over two years. AI-powered navigation software analyzes CT scans and recommends optimal catheter paths, shortening procedure time by up to 18 minutes. Robotic endovascular systems, submitted for regulatory clearance in 2024, promise to improve precision and reduce surgeon fatigue. Custom 3D-printed vascular grafts have entered commercial use, with over 2,000 patient-specific grafts deployed in 2023, and bioprinting initiatives are underway to engineer living vascular tissues.
3.7 Vascular Regeneration and the Future of Vascular Medicine
The frontier of vascular medicine lies in the ability to regenerate blood vessels, repair damaged endothelium, and engineer living vascular tissues that can integrate with the host circulation. Stem cell-based therapies have emerged as a promising approach for vascular regeneration, particularly for peripheral artery disease, where conventional revascularization may be impossible or has failed.
Mesenchymal stem cells, multipotent cells found in bone marrow, adipose tissue, and umbilical cord blood, have shown particular promise for treating peripheral artery disease. These cells can differentiate into vascular support cells and secrete growth factors that stimulate angiogenesis and collateral vessel formation. Early clinical trials using bone marrow-derived stem cells demonstrated reductions in pain, improved lower limb oxygenation, and angiographic evidence of new collateral vessels. However, bone marrow aspiration is painful, and the potency of stem cells declines with age and disease.
Allogeneic umbilical cord-derived mesenchymal stem cells offer an alternative that circumvents these limitations. Retrieved after birth, these young cells are abundant and potent, requiring no painful donation from the patient. Studies have found that cord-derived mesenchymal stem cells more vigorously stimulate angiogenesis than bone marrow-derived cells, and optimized preparatory measures can further enhance their potency. The Stem Cell Medical Center in Antigua and other specialized centers have begun offering these therapies to patients with critical limb ischemia, though large-scale randomized trials are needed to establish efficacy and safety.
Gene-modified induced pluripotent stem cell-derived vascular endothelial cells represent another advanced approach. CRISPR-Cas9 editing has been used to enhance these cells, with eNOS overexpression increasing nitric oxide release by 2.5 times and restoring damaged endothelial barrier function to 91 percent of normal levels. A phase I/II trial of adipose-derived mesenchymal stem cells in 32 patients showed that a single infusion of 1 × 10^8 cells per kilogram was safe, with no serious adverse events, and was associated with a 0.18 mm reduction in average carotid intima-media thickness, a 19 percent decrease in LDL cholesterol, and a 23 percent increase in HDL cholesterol at 6 months. A phase I trial of locally infused iPSC-derived vascular endothelial cells in 10 patients demonstrated that target vessel flow-mediated dilation increased from 4.2 percent to 7.8 percent, with plaque stability improvement in 80 percent of cases.
Bioprinting of vascular tissues is advancing from experimental concept to clinical reality. Three-dimensional printing of patient-specific vascular grafts has already been deployed in over 2,000 cases, and bioprinting initiatives are underway to engineer living vascular tissues with endothelial and smooth muscle layers. Pilot trials in Europe and the United States are expected to complete in 2025, potentially opening the door to off-the-shelf vascular grafts that grow and remodel with the patient, eliminating the need for repeated interventions.
The integration of artificial intelligence into vascular medicine is accelerating. AI-powered navigation software for endovascular procedures, real-time catheter positioning systems, and predictive analytics for patient selection and outcome optimization are transforming clinical practice. Wearable vascular monitoring devices, with over 500,000 units in use globally by late 2023, enable continuous ambulatory assessment of vascular function. Telemedicine now accounts for 19 percent of preoperative and follow-up appointments in vascular care, expanding access and improving efficiency.
4. Discussion
The blood vessels of the human body represent a triumph of biological engineering that continues to inspire awe and demand scientific inquiry. The findings synthesized in this review reveal a vascular system of extraordinary complexity, from the molecular machinery of the endothelial cell to the macroscopic architecture of the great vessels, from the dynamic regulation of vascular tone to the pathological processes that undermine vascular integrity. This complexity is not merely academic; it has profound implications for the prevention and treatment of cardiovascular disease, which remains the leading cause of death and disability worldwide.
The endothelium emerges from this analysis as the central protagonist of vascular health and disease. No longer regarded as a passive lining, the endothelial cell is now recognized as a master regulator of vascular tone, permeability, inflammation, and thrombosis. The impairment of endothelial function, whether by hypertension, hyperlipidemia, diabetes, smoking, or aging, is the initiating event in atherosclerosis and the common pathway through which risk factors exert their deleterious effects. The 2025 AHA/ACC guideline's emphasis on comprehensive risk factor management, including LDL reduction, blood pressure control, and lifestyle modification, reflects this understanding of endothelial dysfunction as the target of cardiovascular prevention.
The recent advances in understanding angiogenesis mechanisms, particularly the recognition of coalescent angiogenesis and the elucidation of mechanical force regulation in vessel formation, have expanded the conceptual framework for vascular biology. These discoveries are not merely additions to textbook knowledge but have practical implications for therapeutic angiogenesis in ischemic tissues and for the development of anti-angiogenic strategies in cancer. The finding that tensile forces between endothelial cells, regulated by specific proteins, are essential for proper vessel assembly opens new avenues for understanding vascular malformations and potentially correcting defective vessel development.
The transformation of vascular surgery by endovascular techniques represents one of the most dramatic shifts in surgical practice in recent decades. The dominance of endovascular approaches for aortic aneurysm repair, peripheral artery disease, and venous disorders has improved patient outcomes, reduced recovery times, and expanded treatment options for patients who would not tolerate open surgery. However, this shift also raises important questions about the maintenance of open surgical skills, the appropriate selection of patients for each approach, and the long-term durability of endovascular repairs. The data from the United Kingdom's National Vascular Registry, showing significant variation in EVAR utilization across centers and persistent challenges in meeting time-to-treatment standards, underscore the need for continued quality improvement and standardization.
The emerging field of vascular regeneration, powered by stem cell therapy, gene editing, and bioprinting, offers the prospect of fundamentally altering the treatment paradigm for vascular disease. Rather than merely bypassing or stenting diseased vessels, regenerative approaches aim to restore normal vascular function by promoting the growth of new vessels, repairing damaged endothelium, and replacing diseased segments with living tissue. The early clinical trial results, while promising, must be interpreted with caution, as the history of stem cell therapy is replete with initial enthusiasm followed by disappointing outcomes in larger trials. Rigorous, well-powered, randomized controlled trials are essential to establish the efficacy, safety, and cost-effectiveness of these novel approaches.
The lymphatic system, long neglected in vascular medicine, deserves greater attention as an integral component of the vascular network. Its roles in fluid homeostasis, immune surveillance, and cancer metastasis are increasingly recognized, and the development of targeted therapies for lymphedema and lymphatic malformations represents an unmet need. The integration of lymphatic biology into vascular medicine curricula and research programs would enhance understanding of the complete vascular system and potentially yield new therapeutic targets.
The global burden of vascular disease continues to escalate, driven by aging populations, the epidemic of obesity and diabetes, and the persistence of smoking in many regions. The 2025 AHA/ACC guideline's emphasis on lifestyle modification, including sodium reduction, the DASH eating plan, weight management, and physical activity, reflects the recognition that pharmacological therapy alone is insufficient to address the root causes of hypertension and atherosclerosis. Population-level strategies, including food reformulation, tobacco control, and urban planning that promotes physical activity, are essential complements to individual clinical interventions.
The challenge of health equity looms large in vascular medicine. The burden of cardiovascular disease is disproportionately concentrated in low- and middle-income countries, where access to diagnostic tools, medications, and surgical interventions is limited. The cost of drug-eluting stents, advanced imaging, and novel biologics places these technologies beyond the reach of many patients who need them most. The development of affordable, scalable solutions, including generic medications, point-of-care diagnostics, and simplified surgical techniques, must be prioritized alongside high-technology innovation.
5. Conclusion
The blood vessels of the human body are far more than passive tubes for blood transport. They are dynamic, living tissues that regulate every aspect of circulation, adapt to changing physiological demands, and participate actively in immune defense, wound healing, and metabolic homeostasis. The approximately 60,000 miles of arteries, veins, and capillaries that course through every tissue represent not merely an anatomical wonder but the fundamental infrastructure of human life.
This review has traced the vascular system from the molecular level of endothelial nitric oxide synthesis to the macroscopic level of aortic surgery, from the embryonic formation of the first blood vessels to the regenerative therapies that may one day replace diseased vessels with living tissue. Along this journey, several themes have emerged with particular clarity. First, the endothelium is the central regulator of vascular health, and its dysfunction is the initiating event in the major vascular diseases. Second, the mechanisms of vascular formation and remodeling are more diverse and complex than previously appreciated, with implications for both therapeutic angiogenesis and anti-angiogenic cancer therapy. Third, the transformation of vascular surgery by endovascular techniques has improved outcomes for many patients but also raises questions about skill maintenance, long-term durability, and equitable access. Fourth, regenerative medicine offers the prospect of restoring rather than merely replacing vascular function, though this promise remains to be validated in large-scale clinical trials.
The future of vascular medicine lies in the integration of these insights into a comprehensive approach that addresses vascular health across the lifespan. This approach must combine molecular understanding with clinical practice, technological innovation with public health strategy, and individual treatment with population-level prevention. The 60,000 miles of blood vessels in every human body deserve nothing less than our full scientific attention, our most innovative therapies, and our deepest commitment to ensuring that the benefits of vascular medicine reach all who need them.
The ancient Greek physician Hippocrates taught that "the veins are the vessels of the blood." We now know that they are far more: they are the vessels of life itself, carrying not only oxygen and nutrients but the molecular signals that coordinate every function of the body. To understand the blood vessels is to understand the essence of human physiology, and to heal them is to heal the very fabric of life.
References
Cleveland Clinic. Blood Vessels: Types, Function & Anatomy. 2021.
StatPearls. Anatomy, Blood Vessels. NCBI Bookshelf. 2023.
Texas Heart Institute. The Cardiovascular System. 2025.
StatPearls. Atherosclerosis. NCBI Bookshelf. 2023.
American Heart Association. Health Threats from High Blood Pressure.
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults. Circulation. 2025.
ScienceDaily. New insights into blood vessel formation. December 17, 2024.
Angiogenesis. The modes of angiogenesis: an updated perspective. 2023;26(4):477-480.
MDPI. Role and Mechanisms of Angiogenesis in Tumours. Biology. 2025;14(7):756.
Cleveland Clinic. Lymphatic Capillaries: Function & Anatomy. 2021.
TeachMeAnatomy. Lymphatic System Anatomy - Vessels - Nodes - Organs. 2025.
Study.com. Lymphatic Vessels: Definition, Function & Location. 2015.
Stem Cell Medical Center. Stem Cell Therapy for Peripheral Artery Disease. 2025.
Frontiers in Cell and Developmental Biology. Research progress of stem cells in the treatment of atherosclerosis. 2026.
Cardio Care Conference. Vascular and Endovascular Surgery. Paris 2025.
Surgical Associates. Endovascular vs. Open Vascular Surgery: Which Is Best for You in 2025? 2026.
Market Growth Reports. Vascular Surgery and Endovascular Procedures Market Size and Trends Research. 2025.
National Vascular Registry. 2025 NVR State of the Nation Report. 2025.
Journal of Vascular Surgery. Operative trends in endovascular and open procedures among vascular fellows. 2025.
Nature. Recent advances and emerging perspectives in vascular and cardiovascular research: A 2025 update. Hypertension Research. 2026.